LINCOLN PHARMACEUTICALS LTD. - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

Download	< Back
16 Sep 2021
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform that the Hon''ble National Company Law Tribunal, Ahmedabad Bench, (''NCLT'') has sanctioned the scheme of Amalgamation of Lincoln Parenteral Limited ('Transferor Company') and Lincoln Pharmaceuticals Limited ('Transferee Company') and their respective shareholders and creditors vide its order dated September 14, 2021 and has been uploaded on the website of Hon''ble NCLT on September 15, 2021. <BR> <BR> The copy of order is attached as annexure to this letter.<BR> <BR> Appointed date of the Scheme is April 01, 2019. The Scheme will be effective upon filing of certified copy of the order of the Hon''ble NCLT with the Registrar of Companies, Gujarat.
View all announcements for LINCOLN PHARMACEUTICALS LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us